Cargando…
Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin
β-Cryptoxanthin (β-CRX) is a carotenoid found in human blood. It is specifically rich in Satsuma mandarin (Citrus unshiu Marc.) but very little in other fruits or vegetables. Several reports indicate the health promoting benefits of β-CRX. As we had reported visceral fat reduction on mildly obese ma...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222848/ https://www.ncbi.nlm.nih.gov/pubmed/22131983 http://dx.doi.org/10.3389/fneur.2011.00067 |
_version_ | 1782217227995447296 |
---|---|
author | Takayanagi, Katsuhiko |
author_facet | Takayanagi, Katsuhiko |
author_sort | Takayanagi, Katsuhiko |
collection | PubMed |
description | β-Cryptoxanthin (β-CRX) is a carotenoid found in human blood. It is specifically rich in Satsuma mandarin (Citrus unshiu Marc.) but very little in other fruits or vegetables. Several reports indicate the health promoting benefits of β-CRX. As we had reported visceral fat reduction on mildly obese male by the oral administration of β-CRX, a detailed mechanism has not been identified. To identify the mechanism, obese model mouse, TSOD was used in the present study. Oral administration of β-CRX repressed body weight, abdominal adipose tissue weight, and serum lipid concentrations on TSOD mice. The outstanding observation is the significant repression of adipocyte hypertrophy. DNA microarray analysis strongly indicates that the oral administration of β-CRX represses the inflammatory cytokine secretion and improves the lipid metabolism and the energy consumption. It also suggests these effects are partly mediated by PPAR-α, not only lipid metabolism and adipocyte differentiation control but possibly internal circadian clock modulation. |
format | Online Article Text |
id | pubmed-3222848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32228482011-11-30 Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin Takayanagi, Katsuhiko Front Neurol Neuroscience β-Cryptoxanthin (β-CRX) is a carotenoid found in human blood. It is specifically rich in Satsuma mandarin (Citrus unshiu Marc.) but very little in other fruits or vegetables. Several reports indicate the health promoting benefits of β-CRX. As we had reported visceral fat reduction on mildly obese male by the oral administration of β-CRX, a detailed mechanism has not been identified. To identify the mechanism, obese model mouse, TSOD was used in the present study. Oral administration of β-CRX repressed body weight, abdominal adipose tissue weight, and serum lipid concentrations on TSOD mice. The outstanding observation is the significant repression of adipocyte hypertrophy. DNA microarray analysis strongly indicates that the oral administration of β-CRX represses the inflammatory cytokine secretion and improves the lipid metabolism and the energy consumption. It also suggests these effects are partly mediated by PPAR-α, not only lipid metabolism and adipocyte differentiation control but possibly internal circadian clock modulation. Frontiers Research Foundation 2011-11-23 /pmc/articles/PMC3222848/ /pubmed/22131983 http://dx.doi.org/10.3389/fneur.2011.00067 Text en Copyright © 2011 Takayanagi. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with. |
spellingShingle | Neuroscience Takayanagi, Katsuhiko Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin |
title | Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin |
title_full | Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin |
title_fullStr | Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin |
title_full_unstemmed | Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin |
title_short | Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin |
title_sort | prevention of adiposity by the oral administration of β-cryptoxanthin |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222848/ https://www.ncbi.nlm.nih.gov/pubmed/22131983 http://dx.doi.org/10.3389/fneur.2011.00067 |
work_keys_str_mv | AT takayanagikatsuhiko preventionofadipositybytheoraladministrationofbcryptoxanthin |